- Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
- Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
- Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
- Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.
Case study: Otis
12-year-old male neutered Catahoula mix

Case background:

- Presenting for an annual wellness exam.
- History of subcutaneous hemangiosarcoma, which was removed 2 years ago.
- Other than this, Otis is doing well at home.

- Physical exam: Moderate dental tartar, Grade 1 murmur (new), Mild arthritic changes to the hips and elbows
- As part of the wellness exam, Dr. Sue ran minimum database blood work as well as Nu.Q ® Vet Cancer Test
- TPR within normal limits

- CBC: Stress leukogram, slightly low platelets: 192,000
- HW Test and Fecal float: Negative
- Chemistry Panel: Mildly elevated globulins: 4.6
- Urinalysis: No significant findings
Otis’s Nu.Q® Vet Cancer Test results
- Results at the Orange level are consistent with an increased risk of cancer in healthy animals over the age of 1 year, and all genders
- The Nu.Q ® Vet Cancer Test identifies patients; however, confirmatory diagnostics should be used to confirm the suspicion of cancer
- Review medical history for previous inflammatory conditions, surgeries, or familial cancer history
RESULT: ORANGE LEVEL/HIGH RISK
What to do next?
-
Proceed to a full work up:
- Chest radiographs
- Abdominal ultrasound
- Refer/advanced imaging – fully body CT
-
- Following further scans and diagnostics, Dr. Sue found a metastatic lesion on thoracic radiographs
- AUS: 6 cm splenic mass

